ABIO

Christopher Graybill Joins ARCA as Vice President, Clinical Development

ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer

ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update

ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders

ARCA Biopharma gets Fast Track designation for experimental COVID-19 treatment

AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation

ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update